J&J Inks $1B Deal To Acquire Aragon Pharmaceuticals
Johnson & Johnson plans to acquire California-based Aragon Pharmaceuticals Inc. in a deal worth up to $1 billion, the companies said on Monday, in an agreement that the New Jersey pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article